Reliability of resting-state electrophysiology in fragile X syndrome

Objective: Fragile X Syndrome (FXS) is the leading monogenic cause of intellectual disability and autism spectrum disorder. Currently, there are no established biomarkers for predicting and monitoring drug effects in FXS, and no approved therapies are available. Previous studies have shown electroph...

Ausführliche Beschreibung

Bibliographische Detailangaben
Hauptverfasser: Rui Liu, Ernest V. Pedapati, Lauren M. Schmitt, Rebecca C. Shaffer, Elizabeth G. Smith, Kelli C. Dominick, Lisa A. DeStefano, Grace Westerkamp, Paul Horn, John A. Sweeney, Craig A. Erickson
Format: Artikel
Sprache:English
Veröffentlicht: Elsevier 2023-12-01
Schriftenreihe:Biomarkers in Neuropsychiatry
Schlagworte:
Online Zugang:http://www.sciencedirect.com/science/article/pii/S2666144623000102